Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy RIL BPCL, Adani Enterprises, Auro Pharma, Jubilant Food; short NMDC, DCB Bank: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Adani Enterprises, Aurobindo Pharma and Jubilant Foodworks and can short NMDC and DCB Bank.

    • Diwali 2017: Top investment picks from Geojit Research

      According to Geojit Research, the top Diwali 2017 picks include names like Yes Bank, KNR Constructions, NBCC, Aurobindo Pharma, Tata Motors, JK Lakshmi Cement, Aarti Industries, Bharat Electronics and UPL.

    • Buy Aurobindo Pharma, BPCL: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Aurobindo Pharma and BPCL.

    • Buy Aurobindo Pharma, Ashok Leyland, Century Textiles: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying Aurobindo Pharma, Ashok Leyland and Century Textiles and Industries.

    • Buy Maruti, Ashok Leyland, Auro Pharma, Federal Bank; sell Indiabulls Real Estate: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Maruti Suzuki, Ashok Leyland, Aurobindo Pharma, Federal Bank, DHFL and JSW Steel and can sell Indiabulls Real Estate.

    • Get ready for a Diwali like never before; 10 market-beating stocks: Sharekhan

      Sharekhan has carefully chosen 10 quality picks to make another market‐beating portfolio. This portfolio is well balanced and provides superior returns, without any unnecessary risk.

    • Market Update: Nifty clings above 10K as midcaps shine; Bharti Infratel, Hindalco top gainers

      The midcap index was the outperforming sector in the early hours of trade led by Biocon, Bharat Financial Inclusion, JSW Energy and Hindustan Zinc while Bharti Infratel followed by Hindalco Industries and Sun Pharmaceutical Industries were the top gainers.

    • Hold Aurobindo Pharma, may move to Rs 930-950: Sandeep Wagle

      According to Sandeep Wagle of powermywealth.com, one may hold Aurobindo Pharma.

    • Remain invested in Aurobindo Pharma: Sharmila Joshi

      According to Sharmila Joshi of sharmilajoshi.com, one may remain invested in Aurobindo Pharma.

    • Buy Tata Communications, CESC; positive on Tata Motors: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests buying Tata Communications and CESC and has a positive view on Tata Motors.

    • Buy Jubilant Foodworks, Future Consumer, Tata Chemicals: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying Jubilant Foodworks, Future Consumer, Tata Chemicals and Raymond.

    • DRL launches Renvela generic in US, price target at Rs 2200: HDFC Securities

      The pharma major Dr Reddys Laboratories (DRL) has launched kidney disease drug Renvela generic in the US market. How big an opportunity can this be for DRL and what does it do to Aurobindo Pharma. In an interview to CNBC-TV18, Amey Chalke of HDFC Securities shared his views and readings on the same.

    • Buy Aurobindo Pharma, Karnataka Bank, Manappuram Finance: CA Rudramurthy BV

      CA Rudramurthy BV, Research Head at Vachana Investments suggests buying Aurobindo Pharma, Karnataka Bank and Manappuram Finance.

    • Tata Steel a momentum play, hold Bombay dyeing; NBCC likley to hit Rs 250: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that Tata Steel a momentum play and recommends holding Bombay dyeing while he feels that NBCC is likley to hit Rs 250.

    • Sell Bharti Airtel, Castrol; buy Reliance Industries, CESC, Dabur: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Bharti Airtel, Castrol India and Aurobindo Pharma and can buy CESC, JSW Steel, Dabur India, Dewan Housing Finance, Reliance Industries and Zee Entertainment.

    • Top pharma names should be looked at, says Basant Maheshwari

      Basant Maheshwari of Basant Maheshwari Wealth is of the view that pharma should be looked at but advises starting from the top notch companies, the bluechips.

    • Hold Aurobindo Pharma: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that one may hold Aurobindo Pharma.

    • Remain invested in Aurobindo Pharma, says Avinnash Gorakssakar

      According to Avinnash Gorakssakar, Market Expert, one may remain invested in Aurobindo Pharma.

    • Here are top technical picks by Geojit Financial Services

      Mahindra CIE (MCIE) is among the top global forging players with a strong presence in both Europe and India. Currently 2/3 of the revenue comes from Europe (split btw CV’s & PV’s) while rest from India (PVs).

    • Here are SP Tulsian's top trading ideas

      In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

    • Buy Aurobindo Pharma, Piramal Enterprises, Karnataka Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying Aurobindo Pharma, Piramal Enterprises and Karnataka Bank.

    • Buy, Sell, Hold: Here are 4 stocks and 4 sectors on brokerages’ radar today

      Indiabulls Housing, Thermax and steel, among others, are being tracked by investors on Thursday.

    • Buy Reliance Industries, ACC, Aurobindo Pharma, Equitas; sell Syndicate Bk: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Reliance Industries, ACC, Aurobindo Pharma and Equitas Holdings and advises selling Syndicate Bank.

    • Buy Aurobindo Pharma, Ashok Leyland, ICICI Prudential, IndusInd Bank: VK Sharma

      VK Sharma of HDFC Securities suggests buying Aurobindo Pharma, Ashok Leyland, ICICI Prudential and IndusInd Bank.

    • Buy Raymond, Adani Enterprises, Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying Raymond, Adani Enterprises and Aurobindo Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347